Aemetis, Inc (AMTX) 10-K Annual Report April 2013

CUPERTINO, Calif. – March 8, 2013 – Aemetis, Inc. (OTCPK: AMTX), an advanced fuels and renewable chemicals company, announced today its preliminary unaudited financial results for the year and fourth quarter ended December 31, 2012.

Financial Results for the Year Ended December 31, 2012

For the year ended December 31, 2012, revenues were $189.0 million, compared to $141.9 million in the same period in 2011. The revenue increase reflects the commencement of operations at our Keyes plant in April 2011. For the year ended December 31, 2012, net loss was $9.1 million, compared to $18.3 million during the same period of 2011.

For the year ended December 31, 2012, operating losses were $19.1 million, compared to $4.5 million during the same period of 2011. This operating loss resulted from $197.9 million in cost of goods sold, $0.6 million in research and development expenses and $9.6 million in general and administrative expenses.

The Company also incurred $19.1 million of interest expense, $11.4 million of loss on debt extinguishment and other expense of $0.2 million offset by a gain on bargain purchase of $40.3 million during the year ended December 31, 2012, which resulted in a net loss of $9.1 million.

For the year ended December 31, 2012, net loss attributable to common stockholders was $0.06 per share, an improvement of $0.12 per share compared to a net loss of $0.18 per share during the same period of 2011.

Financial Results for the Three Months Ended December 31, 2012

For the three months ended December 31, 2012, revenues were $47.2 million, compared to $57.3 million in the same period in 2011. For the three months ended December 31, 2012, net loss was $11.6 million, compared to $2.2 million during the same period of 2011.

For the three months ended December 31, 2012, operating losses were $5.2 million, compared to operating income of $1.8 million during the same period of 2011. The current year operating loss resulted from $49.6 million in cost of goods sold, $0.1 million in research and development expenses and $2.7 million in general and administrative expenses.

The Company also incurred $6.4 million of interest expense which resulted in a net loss of $11.6 million or $0.07 per share.

About Aemetis

Aemetis, Inc. is an advanced fuels and renewable chemicals company headquartered in Cupertino, California. Aemetis owns and operates a 55 million gallon renewable fuels plant in California; and built, owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the east coast of India. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents and nine pending patents on its Z-microbe and related technology for the production of renewable fuels and chemicals. For additional information about Aemetis, please visit www.aemetis.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such statements are identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “goal,” “intends,” “plans,” “potential,” “predicts,” “should,” “will,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Such statements are based on management’s current expectations and are subject to various factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such forward-looking statements. Aemetis may experience significant fluctuations in future operating results due to a number of economic conditions, including, but not limited to, competition in the ethanol and other industries in which the Company operates, commodity market risks including those that may result from current weather conditions, financial market risks, counter-party risks, risks associated with changes to federal policy or regulation, risks associated with the conversion of the Keyes plant to the use of sorghum for ethanol production; and other risks detailed in the Company’s reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2011, and in the Company’s subsequent filings with the SEC. In addition, the Company is not obligated, and does not intend, to update any of its forward-looking statements at any time unless an update is required by applicable securities laws.

(Tables follow)

The following information was filed by Aemetis, Inc (AMTX) on Friday, March 8, 2013 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/738214/000135448813002047/amtx_10k.htm

View differences made from one year to another to evaluate Aemetis, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Aemetis, Inc.

Continue

Assess how Aemetis, Inc's management team is paid from their Annual Proxy

Aemetis, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Aemetis, Inc provided additional information to their SEC Filing as exhibits

Exhibit 21: Subsidiaries

Exhibit 31: Certification

Exhibit 32: Certification

Exhibit 10.72: Amendment To Heiskell Purchasing Agreement

Exhibit 10.76: Amendment To Heiskell Purchasing Agreement

Exhibit 10.77: Amendment No. 1 To Agreement For Repayment Of Note By Share Issuance

Ticker: AMTX
CIK: 738214
Form Type: 10-K Annual Report
Accession Number: 0001354488-13-002047
Submitted to the SEC: Tue Apr 16 2013 5:30:12 PM EST
Accepted by the SEC: Tue Apr 16 2013
Period: Monday, December 31, 2012
Industry: Industrial Organic Chemicals